PDCD1 and neoplasm: Furthermore, the tumor volume, as a function of time, continuously decreased in the PB-020/anti-PD-1 group and the reduction was more prominent than that in each treatment alone (Figure 4C and Figure S7), suggesting the durative and cumulative effect of this combination therapy.